Yingdan Wang

发表

A broadly neutralizing antibody against SARS-CoV-2 Omicron variant infection exhibiting a novel trimer dimer conformation in spike protein binding

Jian K. Liu, Jincun Zhao, Zhenguo Chen, 2022, Cell Research.

Resistance of SARS-CoV-2 Omicron variant to convalescent and CoronaVac vaccine plasma

Jian K. Liu, Jun Xie, Zheng Xiang, 2022, Emerging microbes & infections.

Combating the SARS-CoV-2 Omicron (BA.1) and BA.2 with potent bispecific antibodies engineered from non-Omicron neutralizing antibodies

Jincun Zhao, Zhenguo Chen, Jinghe Huang, 2022, Cell Discovery.

Study on the Associations between Meteorological Factors and the Incidence of Pulmonary Tuberculosis in Xinjiang, China

Zengyun Hu, Haiyan Jiao, Yingdan Wang, 2022, Atmosphere.

Novel sarbecovirus bispecific neutralizing antibodies with exceptional breadth and potency against currently circulating SARS-CoV-2 variants and sarbecoviruses

Jincun Zhao, R. Yan, Yuanyuan Zhang, 2022, Cell discovery.

Combating the SARS-CoV-2 Omicron variant with non-Omicron neutralizing antibodies

Jincun Zhao, Zhenguo Chen, Qimin Wang, 2022, bioRxiv.

M2e‐specific antibodies protect against influenza PR8 virus in an isotype and route dependent manner

Jian K. Liu, Qimin Wang, Peng Zou, 2023, Journal of medical virology.

A bispecific antibody exhibits broad neutralization against SARS-CoV-2 Omicron variants XBB.1.16, BQ.1.1 and sarbecoviruses

Yanqun Wang, Zhaoyong Zhang, Aihua Hao, 2024, Nature communications.